Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
Job title: Principal Scientist Crystallization & Particle Engineering Location: Montpellier, France About the Job As Principal Scientist within our R&D team in Montpellier, youll lead our Crystallization & Particle Engineering Laboratory and drive innovative projects across
Job title: Head of Toxicology Innovation Location: Vitry-Sur-Seine, FR About the job Join the engine of Sanofi’s mission — where deep immunoscience meets bold, AI-powered research. In R&D, you’ll drive breakthroughs that could turn the impossible
Abstract Securing industrial IoT infrastructure is no longer a competitive advantage ; it is a prerequisite for resilient, trustworthy, and sustainable Industry 5.0. Keywords : Industry 5.0, Industrial IoT, Intrusion Detection, Federated Learning, GNN The rapid
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
CompanyAMPERE SOFTWARE TECHNOLOGY Job Description Contexte La planification de mouvement et la prise de décision sont des composants fondamentaux de l’architecture de la conduite autonome. Elles permettent de transformer les données de perception et le modèle
ECL and Laboratory presentation Founded in 1857, École Centrale de Lyon is one of the top 10 engineering schools in France. It trains more than 3,000 students of 50 different nationalities on its campuses in Écully
Joining Mines Saint-Étienne means committing to an institution where science and innovation build a more sustainable future. It is a school of excellence where everyone has the opportunity to unlock their full potential and contribute to
Informations générales Entité de rattachement Le CEA est un acteur majeur de la recherche, au service des citoyens, de léconomie et de lEtat. Il apporte des solutions concrètes à leurs besoins dans quatre domaines principaux :
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI , our proprietary molecule-invention platform, which uniquely combines
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI , our proprietary molecule-invention platform, which uniquely combines
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule‑invention platform, which uniquely combines cutting‑edge
About AQEMIA AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission isQEMI , our proprietary molecule-invention platform, which uniquely combines cutting‑edge
AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI , our proprietary molecule‑invention platform, which uniquely combines cutting‑edge science
GenBio AI develops multiscale foundation models to decode and simulate human biology. Our team is accelerating towards an ambitious future where scientists can unlock humanitys biggest challenges in drug discovery, healthcare, and fundamental research with AIDO
Qubit Pharmaceuticals is a French-American deeptech startup, focusing on discovering novel molecules for complex targets in healthcare and materials science. We leverage proprietary molecular simulation and quantum-physics based modeling technology to develop our own discovery programs that